SoftBank-Backed Relay Therapeutics Jumps in Trading Debut

(Bloomberg) -- Oncology drug developer Relay Therapeutics Inc. surged 75% in its trading debut after expanding its initial public offering to raise $400 million.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.